ANEST IWATA (6381) Q2 2026 earnings summary

Executive summary

• Net sales for FY2025 2Q were ¥26,325 million, down 2.7% year-over-year, with operating profit at ¥2,511 million, down 15.2%, and profit attributable to owners at ¥2,160 million, down 1.5%.

• Ordinary profit and net income exceeded initial forecasts, supported by favorable foreign exchange gains.

• Comprehensive income dropped sharply by 70.4% to ¥1,530 million compared to the previous year.

• Interim dividend of ¥41 per share was maintained as planned, with a new DOE-based shareholder return policy introduced.

• The global economy remained solid, but geopolitical risks and U.S. trade policy uncertainty dampened capital investment, especially in manufacturing.

Financial highlights

• Net sales declined by ¥735 million year-over-year, with a negative foreign exchange impact of ¥556 million.

• Gross profit for the interim period was ¥12,228 million, with a gross margin of 46.5%.

• Operating profit margin decreased to 9.5% from 10.9% year-over-year.

• Equity ratio improved to 68.8%, up 1.1 points from the previous fiscal year-end.

• Cash and cash equivalents at ¥16,482 million, a 6.8% decline from the previous year-end.

Outlook and guidance

• Full-year FY2025 guidance remains unchanged, targeting net sales of ¥58 billion and operating profit of ¥5.55 billion.

• Revenue growth is expected through price increases and sales promotions domestically and internationally.

• Dividend forecast for FY2025 is ¥83.00 per share, unchanged from previous guidance.

• The impact of U.S. trade policy is expected to be minor, with tariff costs passed on to sales prices.